Ticker
FHTXCompany Name
FOGHORN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -90.49M | -374.35% | $ 24.17M |
3/31/2025 | $ -95.03M | -404.31% | $ 23.5M |
12/31/2024 | $ -100.41M | -444.24% | $ 22.6M |
9/30/2024 | $ -103.43M | -405.36% | $ 25.52M |
6/30/2024 | $ -109.63M | -311.59% | $ 35.19M |
3/31/2024 | $ -116.27M | -343.02% | $ 33.9M |
12/31/2023 | $ -118.11M | -345.79% | $ 34.16M |
9/30/2023 | $ -119.49M | -366.87% | $ 32.57M |
6/30/2023 | $ -112.27M | -516.73% | $ 21.73M |
3/31/2023 | $ -109.1M | -529.18% | $ 20.62M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for FOGHORN THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -46.34M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Sep 30, 2021
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |